Centene (NYSE:CNC) Price Target Raised to $39.00 at Deutsche Bank Aktiengesellschaft

Centene (NYSE:CNC) had its target price lifted by investment analysts at Deutsche Bank Aktiengesellschaft from $32.00 to $39.00 in a report issued on Tuesday,MarketScreener reports. The brokerage currently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s target price suggests a potential upside of 1.79% from the stock’s previous close.

Several other research analysts have also recently issued reports on CNC. Sanford C. Bernstein restated an “outperform” rating and issued a $59.00 target price on shares of Centene in a report on Tuesday, January 6th. Cantor Fitzgerald restated a “neutral” rating and issued a $41.00 price objective on shares of Centene in a research report on Monday. Mizuho set a $47.00 target price on shares of Centene in a report on Friday, January 9th. Oppenheimer reissued an “outperform” rating and set a $45.00 price objective on shares of Centene in a research note on Thursday, October 30th. Finally, UBS Group set a $42.00 target price on Centene and gave the company a “neutral” rating in a report on Thursday, October 30th. Three research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $41.25.

Centene Trading Up 0.7%

Shares of NYSE CNC opened at $38.32 on Tuesday. The stock has a market capitalization of $18.83 billion, a PE ratio of -2.79, a PEG ratio of 0.88 and a beta of 0.48. Centene has a twelve month low of $25.08 and a twelve month high of $66.03. The company has a current ratio of 1.10, a quick ratio of 1.08 and a debt-to-equity ratio of 0.87. The stock has a fifty day simple moving average of $42.03 and a 200-day simple moving average of $36.07.

Centene (NYSE:CNC) last posted its quarterly earnings results on Friday, February 6th. The company reported ($1.19) EPS for the quarter, topping the consensus estimate of ($1.22) by $0.03. The company had revenue of $49.73 billion during the quarter, compared to analysts’ expectations of $48.41 billion. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. The firm’s revenue was up 21.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.80 EPS. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. On average, equities analysts forecast that Centene will post 6.86 earnings per share for the current year.

Institutional Investors Weigh In On Centene

Hedge funds have recently made changes to their positions in the company. WPG Advisers LLC boosted its position in Centene by 44.5% during the third quarter. WPG Advisers LLC now owns 915 shares of the company’s stock valued at $33,000 after purchasing an additional 282 shares during the last quarter. Prime Capital Investment Advisors LLC grew its stake in Centene by 5.7% during the fourth quarter. Prime Capital Investment Advisors LLC now owns 5,975 shares of the company’s stock worth $246,000 after buying an additional 324 shares during the last quarter. Burney Co. lifted its position in Centene by 3.8% during the 4th quarter. Burney Co. now owns 9,053 shares of the company’s stock worth $373,000 after buying an additional 331 shares in the last quarter. Versant Capital Management Inc increased its stake in shares of Centene by 11.6% in the 3rd quarter. Versant Capital Management Inc now owns 3,421 shares of the company’s stock valued at $122,000 after buying an additional 355 shares during the period. Finally, Sapient Capital LLC boosted its stake in Centene by 4.0% during the 4th quarter. Sapient Capital LLC now owns 9,442 shares of the company’s stock worth $389,000 after acquiring an additional 359 shares during the last quarter. Hedge funds and other institutional investors own 93.63% of the company’s stock.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.